{"DataElement":{"publicId":"2737130","version":"2","preferredName":"Clinical Significant Comorbidity Type","preferredDefinition":"A description of the clinically significant co-existing disease.","longName":"CLN_SIG_CMRBD_TP","context":"NHLBI","contextVersion":"1","DataElementConcept":{"publicId":"2737101","version":"1","preferredName":"Clinical Significant Comorbidity Type","preferredDefinition":"Relating to the examination and treatment of patients dependent on direct observation.  The term may also refer to the institution (clinic) providing this activity._A term applied to differences, correlations, cause-and-effect relationships, etc., to indicate that they are noticeable, probably too closely correlated to be attributed to chance and therefore indicating a systematic relation: substantial, fairly large; also having consequence or import, important in effect or meaning. In statistics significant ordinarily indicates a probability of not less than 95 percent, while highly significant indicates a probability of not less than 99 percent._The coexistence of two or more disease processes._Something distinguishable as an identifiable class based on common qualities.","longName":"CLN_SIG_CMRBD_TP","context":"NHLBI","contextVersion":"1","ObjectClass":{"publicId":"2737098","version":"1","preferredName":"Clinical Significant Comorbidity","preferredDefinition":"Having to do with the examination and treatment of patients.:A term applied to differences, correlations, cause-and-effect relationships, etc., to indicate that they are noticeable, probably too closely correlated to be attributed to chance and therefore indicating a systematic relation: substantial, fairly large; also having consequence or import, important in effect or meaning. In statistics significant ordinarily indicates a probability of not less than 95 percent, while highly significant indicates a probability of not less than 99 percent.:The coexistence of two or more disease processes.","longName":"C25398:C41130:C16457","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Clinical","conceptCode":"C25398","definition":"Relating to the examination and treatment of patients dependent on direct observation.  The term may also refer to the institution (clinic) providing this activity.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"2"},{"longName":"Significant","conceptCode":"C41130","definition":"A term applied to differences, correlations, cause-and-effect relationships, etc., to indicate that they are noticeable, probably too closely correlated to be attributed to chance and therefore indicating a systematic relation: substantial, fairly large; also having consequence or import, important in effect or meaning. In statistics significant ordinarily indicates a probability of not less than 95 percent, while highly significant indicates a probability of not less than 99 percent.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Comorbidity","conceptCode":"C16457","definition":"The coexistence of two or more disease processes.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"4958A7D5-8CF1-5810-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2008-03-26","endDate":null,"createdBy":"ALEYR","dateCreated":"2008-03-26","modifiedBy":"SBREXT","dateModified":"2008-03-31","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"Property":{"publicId":"2223243","version":"1","preferredName":"Type","preferredDefinition":"A subdivision of a particular kind of thing.","longName":"C25284","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Type","conceptCode":"C25284","definition":"Something distinguishable as an identifiable class based on common qualities.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":"NCI Thesaurus","workflowStatus":"RELEASED","registrationStatus":"Application","id":"F629F5E5-DE63-1DFD-E034-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2005-05-02","endDate":null,"createdBy":"UMLLOADER","dateCreated":"2005-05-02","modifiedBy":"SBREXT","dateModified":"2007-11-07","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"ConceptualDomain":{"publicId":"2435022","version":"1","preferredName":"Disease, Disorder or Finding","preferredDefinition":"Specification of human conditions relevant to cancer. This includes observations, test results, history, and other concepts relevant to characterization of human cancer-related conditions. Non-neoplastic conditions of interest are also included.","longName":"C7057","context":"NCIP","contextVersion":"1","origin":"NCI Thesaurus","workflowStatus":"RELEASED","registrationStatus":"Application","id":"0741B16D-87D9-26CD-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2005-12-06","endDate":null,"createdBy":"CURTIST","dateCreated":"2005-12-06","modifiedBy":"SBR","dateModified":"2006-12-20","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":"NMDP:National Marrow Donor Program","workflowStatus":"RELEASED","registrationStatus":"Application","id":"4958A7D5-8CFF-5810-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2008-03-26","endDate":null,"createdBy":"ALEYR","dateCreated":"2008-03-26","modifiedBy":"SBR","dateModified":"2016-06-06","changeDescription":".","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"ValueDomain":{"publicId":"2737105","version":"1.1","preferredName":"Comorbidity Type","preferredDefinition":"The coexistence of two or more disease processes._Type; a subdivision of a particular kind of thing.","longName":"CMRBDTY_TP","context":"NHLBI","contextVersion":"1","type":"Enumerated","dataType":"CHARACTER","minLength":null,"maxLength":"100","minValue":null,"maxValue":null,"decimalPlace":null,"PermissibleValues":[{"value":"Diabetes","valueDescription":"Diabetes.","ValueMeaning":{"publicId":"2737106","version":"1","preferredName":"Diabetes.","longName":"2737106","preferredDefinition":"Requiring treatment with insulin or oral hypoglycemic drugs in the last 4 weeks but not diet alone.","context":"NCIP","contextVersion":"1","Concepts":[],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"495A4F7C-9111-4C68-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":null,"endDate":null,"createdBy":"ALEYR","dateCreated":"2008-03-26","modifiedBy":"COOPERM","dateModified":"2019-10-22","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"956FF73C-E72B-0EC3-E053-F662850AEE38","beginDate":"2008-03-26","endDate":null,"createdBy":"KUMMEROA","dateCreated":"2019-10-21","modifiedBy":"ONEDATA","dateModified":"2019-10-21","deletedIndicator":"No"},{"value":"Cardiac","valueDescription":"cardiac.","ValueMeaning":{"publicId":"2737107","version":"1","preferredName":"cardiac.","longName":"2737107","preferredDefinition":"Any history of coronary artery disease (one or more vessel-coronary artery stenosis requiring medical treatment, stent, or bypass graft), congestive heart failure, myocardial infarction, OR ejection fraction less than or equal to 50% on the most recent test.","context":"NCIP","contextVersion":"1","Concepts":[],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"495A4F7C-914B-4C68-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":null,"endDate":null,"createdBy":"ALEYR","dateCreated":"2008-03-26","modifiedBy":"KUMMEROA","dateModified":"2019-10-23","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"956FF73C-E735-0EC3-E053-F662850AEE38","beginDate":"2008-03-26","endDate":null,"createdBy":"KUMMEROA","dateCreated":"2019-10-21","modifiedBy":"ONEDATA","dateModified":"2019-10-21","deletedIndicator":"No"},{"value":"Arrhythmia","valueDescription":"Arrhythmia.","ValueMeaning":{"publicId":"2737108","version":"1","preferredName":"Arrhythmia.","longName":"2737108","preferredDefinition":"Any history of atrial fibrillation or flutter, sick sinus syndrome, or ventricular arrhythmias requiring treatment.","context":"NCIP","contextVersion":"1","Concepts":[],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"495A4F7C-9170-4C68-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":null,"endDate":null,"createdBy":"ALEYR","dateCreated":"2008-03-26","modifiedBy":"COOPERM","dateModified":"2019-10-23","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"956FF73C-E73F-0EC3-E053-F662850AEE38","beginDate":"2008-03-26","endDate":null,"createdBy":"KUMMEROA","dateCreated":"2019-10-21","modifiedBy":"ONEDATA","dateModified":"2019-10-21","deletedIndicator":"No"},{"value":"Solid tumor, prior","valueDescription":"Solid tumor, prior.","ValueMeaning":{"publicId":"2737115","version":"1","preferredName":"Solid tumor, prior.","longName":"2737115","preferredDefinition":"Solid tumor treated at any time point in the patient's history, excluding nonmelanoma skin cancer.","context":"NCIP","contextVersion":"1","Concepts":[],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"495AA903-837C-4AFF-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":null,"endDate":null,"createdBy":"ALEYR","dateCreated":"2008-03-26","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"956FF73C-E749-0EC3-E053-F662850AEE38","beginDate":"2008-03-26","endDate":null,"createdBy":"KUMMEROA","dateCreated":"2019-10-21","modifiedBy":"ONEDATA","dateModified":"2019-10-21","deletedIndicator":"No"},{"value":"Renal, moderate / severe","valueDescription":"Renal, moderate / severe.","ValueMeaning":{"publicId":"2737117","version":"1","preferredName":"Renal, moderate / severe.","longName":"2737117","preferredDefinition":"Serum creatinine > 2 mg/dL or > 177 umol/L; on dialysis during the 4 weeks prior to transplant; OR prior renal transplantation.","context":"NCIP","contextVersion":"1","Concepts":[],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"495AA903-83C6-4AFF-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":null,"endDate":null,"createdBy":"ALEYR","dateCreated":"2008-03-26","modifiedBy":"KUMMEROA","dateModified":"2019-10-23","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"956FF73C-E753-0EC3-E053-F662850AEE38","beginDate":"2008-03-26","endDate":null,"createdBy":"KUMMEROA","dateCreated":"2019-10-21","modifiedBy":"ONEDATA","dateModified":"2019-10-21","deletedIndicator":"No"},{"value":"Pulmonary, severe","valueDescription":"Pulmonary, severe.","ValueMeaning":{"publicId":"2737118","version":"1","preferredName":"Pulmonary, severe.","longName":"2737118","preferredDefinition":"Corrected diffusion capacity of carbon monoxide and/or FEV1 of less than or equal to 65% or dyspnea at rest attributed to pulmonary disease or the need for intermittent or continuous oxygen during the 4 weeks prior to transplant.","context":"NCIP","contextVersion":"1","Concepts":[],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"495AA903-83EB-4AFF-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":null,"endDate":null,"createdBy":"ALEYR","dateCreated":"2008-03-26","modifiedBy":"KUMMEROA","dateModified":"2019-10-23","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"956FF73C-E75D-0EC3-E053-F662850AEE38","beginDate":"2008-03-26","endDate":null,"createdBy":"KUMMEROA","dateCreated":"2019-10-21","modifiedBy":"ONEDATA","dateModified":"2019-10-21","deletedIndicator":"No"},{"value":"Pulmonary, moderate","valueDescription":"Pulmonary, moderate.","ValueMeaning":{"publicId":"2737119","version":"1","preferredName":"Pulmonary, moderate.","longName":"2737119","preferredDefinition":"Corrected diffusion capacity of carbon monoxide and/or FEV1 of 66-80% or dyspnea on slight activity attributed to pulmonary disease at transplant.","context":"NCIP","contextVersion":"1","Concepts":[],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"495AA903-8410-4AFF-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":null,"endDate":null,"createdBy":"ALEYR","dateCreated":"2008-03-26","modifiedBy":"COOPERM","dateModified":"2019-10-22","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"956FF73C-E767-0EC3-E053-F662850AEE38","beginDate":"2008-03-26","endDate":null,"createdBy":"KUMMEROA","dateCreated":"2019-10-21","modifiedBy":"ONEDATA","dateModified":"2019-10-21","deletedIndicator":"No"},{"value":"Peptic ulcer","valueDescription":"Peptic ulcer.","ValueMeaning":{"publicId":"2737121","version":"1","preferredName":"Peptic ulcer.","longName":"2737121","preferredDefinition":"Any history of peptic (gastric or duodenal) ulcer confirmed by endoscopy or radiologic diagnosis requiring treatment.","context":"NCIP","contextVersion":"1","Concepts":[],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"495AA903-845A-4AFF-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":null,"endDate":null,"createdBy":"ALEYR","dateCreated":"2008-03-26","modifiedBy":"COOPERM","dateModified":"2019-10-22","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"956FF73C-E771-0EC3-E053-F662850AEE38","beginDate":"2008-03-26","endDate":null,"createdBy":"KUMMEROA","dateCreated":"2019-10-21","modifiedBy":"ONEDATA","dateModified":"2019-10-21","deletedIndicator":"No"},{"value":"Obesity","valueDescription":"Obesity.","ValueMeaning":{"publicId":"2737122","version":"1","preferredName":"Obesity.","longName":"2737122","preferredDefinition":"Patients older than 18 years with a body mass index (BMI) > 35 kg/m2 prior to the start of conditioning or a BMI of the 95th percentile or higher for patients aged 18 years or younger.","context":"NCIP","contextVersion":"1","Concepts":[],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"495AA903-847F-4AFF-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":null,"endDate":null,"createdBy":"ALEYR","dateCreated":"2008-03-26","modifiedBy":"KUMMEROA","dateModified":"2019-10-23","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"956FF73C-E77B-0EC3-E053-F662850AEE38","beginDate":"2008-03-26","endDate":null,"createdBy":"KUMMEROA","dateCreated":"2019-10-21","modifiedBy":"ONEDATA","dateModified":"2019-10-21","deletedIndicator":"No"},{"value":"Inflammatory bowel disease","valueDescription":"Inflammatory bowel disease.","ValueMeaning":{"publicId":"2737123","version":"1","preferredName":"Inflammatory bowel disease.","longName":"2737123v1.00","preferredDefinition":"Any history of Crohn's disease or ulcerative colitis requiring treatment.","context":"NCIP","contextVersion":"1","Concepts":[],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"495AA903-84A4-4AFF-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":null,"endDate":null,"createdBy":"ALEYR","dateCreated":"2008-03-26","modifiedBy":"DWARZEL","dateModified":"2023-01-25","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"956FF73C-E785-0EC3-E053-F662850AEE38","beginDate":"2008-03-26","endDate":null,"createdBy":"KUMMEROA","dateCreated":"2019-10-21","modifiedBy":"ONEDATA","dateModified":"2019-10-21","deletedIndicator":"No"},{"value":"Infection","valueDescription":"Infection.","ValueMeaning":{"publicId":"2737124","version":"1","preferredName":"Infection.","longName":"2737124","preferredDefinition":"Includes a documented infection, fever of unknown origin, or pulmonary nodules suspicious for fungal pneumonia or a positive PPD test requiring prophylaxis against tuberculosis. Patients must have started antimicrobial treatment before Day 0 with continuation of antimicrobial treatment after Day 0.","context":"NCIP","contextVersion":"1","Concepts":[],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"495AA903-84C9-4AFF-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":null,"endDate":null,"createdBy":"ALEYR","dateCreated":"2008-03-26","modifiedBy":"COOPERM","dateModified":"2019-10-22","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"956FF73C-E78F-0EC3-E053-F662850AEE38","beginDate":"2008-03-26","endDate":null,"createdBy":"KUMMEROA","dateCreated":"2019-10-21","modifiedBy":"ONEDATA","dateModified":"2019-10-21","deletedIndicator":"No"},{"value":"Hepatic, moderate / severe","valueDescription":"Hepatic, moderate / severe.","ValueMeaning":{"publicId":"2737125","version":"1","preferredName":"Hepatic, moderate / severe.","longName":"2737125","preferredDefinition":"Liver cirrhosis, bilirubin > 1.5 × upper limit of normal, or AST/ALT > 2.5 × upper limit of normal.","context":"NCIP","contextVersion":"1","Concepts":[],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"495AA903-84EE-4AFF-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":null,"endDate":null,"createdBy":"ALEYR","dateCreated":"2008-03-26","modifiedBy":"COOPERM","dateModified":"2019-10-22","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"956FF73C-E799-0EC3-E053-F662850AEE38","beginDate":"2008-03-26","endDate":null,"createdBy":"KUMMEROA","dateCreated":"2019-10-21","modifiedBy":"ONEDATA","dateModified":"2019-10-21","deletedIndicator":"No"},{"value":"Hepatic, mild","valueDescription":"Hepatic, mild.","ValueMeaning":{"publicId":"2737126","version":"1","preferredName":"Hepatic, mild.","longName":"2737126","preferredDefinition":"Bilirubin > upper limit of normal to 1.5 × upper limit of normal, or AST/ALT > upper limit of normal to 2.5 × upper limit of normal at the time of transplant OR any history of hepatitis B or hepatitis C infection.","context":"NCIP","contextVersion":"1","Concepts":[],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"495AA903-8513-4AFF-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":null,"endDate":null,"createdBy":"ALEYR","dateCreated":"2008-03-26","modifiedBy":"COOPERM","dateModified":"2019-10-22","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"956FF73C-E7A3-0EC3-E053-F662850AEE38","beginDate":"2008-03-26","endDate":null,"createdBy":"KUMMEROA","dateCreated":"2019-10-21","modifiedBy":"ONEDATA","dateModified":"2019-10-21","deletedIndicator":"No"},{"value":"Heart valve disease","valueDescription":"Heart valve disease.","ValueMeaning":{"publicId":"2737127","version":"1","preferredName":"Heart valve disease.","longName":"2737127","preferredDefinition":"At least a moderate to severe degree of valve stenosis or insufficiency as determined by Echo; prosthetic mitral or aortic valve; or symptomatic mitral valve prolapse.","context":"NCIP","contextVersion":"1","Concepts":[],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"495AA903-8538-4AFF-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":null,"endDate":null,"createdBy":"ALEYR","dateCreated":"2008-03-26","modifiedBy":"COOPERM","dateModified":"2019-10-22","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"956FF73C-E7AD-0EC3-E053-F662850AEE38","beginDate":"2008-03-26","endDate":null,"createdBy":"KUMMEROA","dateCreated":"2019-10-21","modifiedBy":"ONEDATA","dateModified":"2019-10-21","deletedIndicator":"No"},{"value":"Cerebrovascular disease","valueDescription":"Cerebrovascular disease.","ValueMeaning":{"publicId":"2737128","version":"1","preferredName":"Cerebrovascular disease.","longName":"2737128","preferredDefinition":"Any history of transient ischemic attack, subarachnoid hemorrhage or cerebral thrombosis, embolism, or hemorrhage.","context":"NCIP","contextVersion":"1","Concepts":[],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"495AA903-8573-4AFF-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":null,"endDate":null,"createdBy":"ALEYR","dateCreated":"2008-03-26","modifiedBy":"COOPERM","dateModified":"2019-10-22","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"956FF73C-E7B7-0EC3-E053-F662850AEE38","beginDate":"2008-03-26","endDate":null,"createdBy":"KUMMEROA","dateCreated":"2019-10-21","modifiedBy":"ONEDATA","dateModified":"2019-10-21","deletedIndicator":"No"},{"value":"Other","valueDescription":"Other","ValueMeaning":{"publicId":"2559653","version":"1","preferredName":"Other","longName":"2559653","preferredDefinition":"Different than the one(s) previously specified or mentioned.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Other","conceptCode":"C17649","definition":"Different than the one(s) previously specified or mentioned.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"2509CE87-B612-5C23-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2002-02-13","endDate":null,"createdBy":"SBR","dateCreated":"2002-02-13","modifiedBy":"GDEEN","dateModified":"2023-12-28","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"956FF73C-E7C1-0EC3-E053-F662850AEE38","beginDate":"2008-06-07","endDate":null,"createdBy":"KUMMEROA","dateCreated":"2019-10-21","modifiedBy":"ONEDATA","dateModified":"2019-10-21","deletedIndicator":"No"},{"value":"Psychiatric disturbance","valueDescription":"Psychiatric disturbance","ValueMeaning":{"publicId":"2751268","version":"1","preferredName":"Psychiatric disturbance","longName":"2751268","preferredDefinition":"Presence of any mood (e.g., depression), anxiety, or other psychiatric disorder (e.g. bipolar disorder or schizophrenia) requiring continuous treatment in the last 4 weeks.","context":"NCIP","contextVersion":"1","Concepts":[],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"4DBF93E0-C3B0-0998-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":null,"endDate":null,"createdBy":"ALEYR","dateCreated":"2008-05-21","modifiedBy":"COOPERM","dateModified":"2019-10-22","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"956FF73C-E7CB-0EC3-E053-F662850AEE38","beginDate":"2008-03-26","endDate":null,"createdBy":"KUMMEROA","dateCreated":"2019-10-21","modifiedBy":"ONEDATA","dateModified":"2019-10-21","deletedIndicator":"No"},{"value":"Rheumatologic","valueDescription":"Rheumatologic (2)","ValueMeaning":{"publicId":"2590652","version":"1","preferredName":"Rheumatologic (2)","longName":"2590652","preferredDefinition":"Any history of a rheumatologic disease (e.g., systemic lupus erythematosis, rheumatoid arthritis, polymyositis, mixed connective tissue disease, or polymyalgia rheumatica, etc.) requiring treatment. (Do NOT include degenerative joint disease, osteoarthritis).","context":"NCIP","contextVersion":"1","Concepts":[],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"27CDB15B-105A-0A0D-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2007-01-24","endDate":null,"createdBy":"CAMPBELB","dateCreated":"2007-01-24","modifiedBy":"COOPERM","dateModified":"2019-10-22","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"956FF73C-E7D5-0EC3-E053-F662850AEE38","beginDate":"2008-03-26","endDate":null,"createdBy":"KUMMEROA","dateCreated":"2019-10-21","modifiedBy":"ONEDATA","dateModified":"2019-10-21","deletedIndicator":"No"},{"value":"Prior malignancy","valueDescription":"Prior Malignant Neoplasm","ValueMeaning":{"publicId":"2774527","version":"1","preferredName":"Prior Malignant Neoplasm","longName":"2774527","preferredDefinition":"Earlier in time or order.: A tumor composed of atypical neoplastic, often pleomorphic cells that invade other tissues.  Malignant neoplasms usually metastasize to distant anatomic sites and may recur after excision.  The most common malignant neoplasms are carcinomas (adenocarcinomas or squamous cell carcinomas), Hodgkin's and non-Hodgkin's lymphomas, leukemias, melanomas, and sarcomas. -- 2004","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Prior","conceptCode":"C25629","definition":"Earlier in time or order.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Malignant Neoplasm","conceptCode":"C9305","definition":"A neoplasm composed of atypical neoplastic, often pleomorphic cells that invade other tissues. Malignant neoplasms often metastasize to distant anatomic sites and may recur after excision. The most common malignant neoplasms are carcinomas, Hodgkin and non-Hodgkin lymphomas, leukemias, melanomas, and sarcomas.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"545BF7ED-22A1-164E-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":null,"endDate":null,"createdBy":"NYCHM","dateCreated":"2008-08-13","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"956FF73C-E7E0-0EC3-E053-F662850AEE38","beginDate":"2018-09-26","endDate":null,"createdBy":"KUMMEROA","dateCreated":"2019-10-21","modifiedBy":"ONEDATA","dateModified":"2019-10-21","deletedIndicator":"No"}],"ConceptualDomain":{"publicId":"2435022","version":"1","preferredName":"Disease, Disorder or Finding","preferredDefinition":"Specification of human conditions relevant to cancer. This includes observations, test results, history, and other concepts relevant to characterization of human cancer-related conditions. Non-neoplastic conditions of interest are also included.","longName":"C7057","context":"NCIP","contextVersion":"1","origin":"NCI Thesaurus","workflowStatus":"RELEASED","registrationStatus":"Application","id":"0741B16D-87D9-26CD-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2005-12-06","endDate":null,"createdBy":"CURTIST","dateCreated":"2005-12-06","modifiedBy":"SBR","dateModified":"2006-12-20","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"RepresentationTerm":{"publicId":"2737104","version":"1","preferredName":"Comorbidity Type","preferredDefinition":"The coexistence of two or more disease processes.:Type; a subdivision of a particular kind of thing.","longName":"C16457:C25284","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Comorbidity","conceptCode":"C16457","definition":"The coexistence of two or more disease processes.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Type","conceptCode":"C25284","definition":"Something distinguishable as an identifiable class based on common qualities.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"495A4F7C-90EB-4C68-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2008-03-26","endDate":null,"createdBy":"ALEYR","dateCreated":"2008-03-26","modifiedBy":"SBREXT","dateModified":"2008-03-31","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":"NMDP:National Marrow Donor Program","workflowStatus":"RELEASED","registrationStatus":"Application","id":"956FF73C-E715-0EC3-E053-F662850AEE38","latestVersionIndicator":"Yes","beginDate":"2008-03-26","endDate":null,"createdBy":"KUMMEROA","dateCreated":"2019-10-21","modifiedBy":"ZHWENDY","dateModified":"2022-07-18","changeDescription":".","administrativeNotes":"7/18/2022: fixed the box symbol in VM definition.wz","unresolvedIssues":null,"deletedIndicator":"No"},"ClassificationSchemes":[{"publicId":"2964591","version":"1","longName":"Eligibility Criteria","context":"NCIP","ClassificationSchemeItems":[{"publicId":"2965104","version":"1","longName":"Structured Eligibility Criteria","context":"NCIP"},{"publicId":"3070844","version":"1","longName":"Baseline/Concomitant Condition","context":"NCIP"}]},{"publicId":"3553940","version":"1","longName":"BRIDG","context":"NHLBI","ClassificationSchemeItems":[{"publicId":"4133055","version":"1","longName":"Version 3.2","context":"NHLBI"}]},{"publicId":"6685474","version":"1","longName":"Artificial Neural Network Algorithm for BRIDG Mapping","context":"NCIP","ClassificationSchemeItems":[{"publicId":"6685476","version":"1","longName":"Training Set","context":"NCIP"}]}],"AlternateNames":[{"name":"PerformedDiagnosis:resultClassification ","type":"HCT_BRIDG","context":"NHLBI"}],"ReferenceDocuments":[{"name":"What was the clinically signi","type":"Preferred Question Text","description":"What was the clinically significant co-existing disease or organ impairment?","url":null,"context":"NHLBI"},{"name":"BRIDG mapping path for CDE:2737130","type":"BRIDG Mapping Path","description":"\"PerformedDiagnosis [primary] > AssessedResultRelationship > PerformedObservation [assessment] > AssessedResultRelationship > PerformedDiagnosis.resultClassification(ANY=>CD).code [secondary] WHERE  PerformedDiagnosis.value [primary] = \"\"Acute Myelogenous Leukemia(AML)\"\" OR \"\"Chronic Myelogenous Leukemia(CML)\"\" OR \"\"Myelodysplasia Syndrome(MDS)\"\"  AND PerformedDiagnosis [primary] > PerformedProcedure [overall HCT process] AND PerformedObservation [assessment] > PerformedClinicalInterpretation.value = \"\"CoMorbid\"\" AND PerformedClinicalInterpretation.clinicallySignificantIndicator = \"\"true\"\" AND PerformedObservation [assessment] > DefinedObservation.nameCode = \"\"Assess Comorbidity and Clinical Significance\"\"\"","url":null,"context":"NHLBI"}],"origin":"NMDP:National Marrow Donor Program","workflowStatus":"RELEASED","registrationStatus":"Application","id":"CADB33A5-5D36-1105-E053-4EBD850A6A8B","latestVersionIndicator":"Yes","beginDate":"2008-03-26","endDate":null,"createdBy":"KUMMEROA","dateCreated":"2021-08-31","modifiedBy":"KUMMEROA","dateModified":"2021-08-31","changeDescription":". CDE updated with v1.1 VD. System generated def displayed as alt def. AK 11/17/14","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"}}